Mark Berney

Mark completed his PhD in chemistry at Trinity College Dublin. His research focused on developing inhibitors for an enzyme involved in DNA damage repair, a promising strategy for addressing drug-resistance in cancer chemotherapy. Following this, Mark obtained a Fulbright award to move to the University of Chicago.  Here he was part of a team developing an mRNA-targeting tool to upregulate translation. After returning to Ireland, Mark joined NIBRT in 2022 to work on an SFI-funded project on RNA stabilisation.